Alitretinoin Completed Phase 2 Trials for Psoriasis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01245140Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis